关注
Ellen H.M. Moors
Ellen H.M. Moors
Professor Sustainable Innovation
在 uu.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
A network of heterogeneous hydrogen bonds in GNRA tetraloops
FM Jucker, HA Heus, PF Yip, EHM Moors, A Pardi
Journal of molecular biology 264 (5), 968-980, 1996
4321996
Towards cleaner production: barriers and strategies in the base metals producing industry
EHM Moors, KF Mulder, PJ Vergragt
Journal of cleaner production 13 (7), 657-668, 2005
2222005
Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors
L Strohm, C Hehakaya, ER Ranschaert, WPC Boon, EHM Moors
European radiology 30, 5525-5532, 2020
2042020
Science, technology and the ‘grand challenge’of ageing—Understanding the socio-material constitution of later life
A Peine, A Faulkner, B Jæger, E Moors
Technological Forecasting and Social Change 93, 1-9, 2015
1892015
Traditional and modern technology assessment: toward a toolkit
J Van Den Ende, K Mulder, M Knot, E Moors, P Vergragt
Technological Forecasting and Social Change 58 (1-2), 5-21, 1998
1851998
Demand articulation in emerging technologies: intermediary user organisations as co-producers?
WPC Boon, EHM Moors, S Kuhlmann, REHM Smits
Research Policy 40 (2), 242-252, 2011
1652011
Clinical comparability and European biosimilar regulations
H Schellekens, E Moors
Nature biotechnology 28 (1), 28-31, 2010
1352010
Reducing post-harvest food losses through innovative collaboration: Insights from the Colombian and Mexican avocado supply chains.
C Arias Bustos, EHM Moors
Journal of Cleaner Production, 2018
1292018
Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
PJK Van Meer, M Kooijman, V Brinks, CC Gispen-de Wied, B Silva-Lima, ...
MAbs 5 (5), 810-816, 2013
1292013
Exploring emerging technologies using metaphors–a study of orphan drugs and pharmacogenomics
W Boon, E Moors
Social science & medicine 66 (9), 1915-1927, 2008
1172008
Institutional power play in innovation systems: The case of Herceptin®
P Kukk, EHM Moors, MP Hekkert
Research Policy 45 (8), 1558-1569, 2016
1022016
Demand articulation in intermediary organisations: The case of orphan drugs in the Netherlands
WPC Boon, EHM Moors, S Kuhlmann, REHM Smits
Technological forecasting and social change 75 (5), 644-671, 2008
982008
Caring for healthcare entrepreneurs—Towards successful entrepreneurial strategies for sustainable innovations in Dutch healthcare
M Janssen, EHM Moors
Technological Forecasting and Social Change 80 (7), 1360-1374, 2013
972013
Technology strategies for sustainable metals production systems: a case study of primary aluminium production in The Netherlands and Norway
EHM Moors
Journal of cleaner production 14 (12-13), 1121-1138, 2006
812006
The dynamics of innovation: a multilevel co-evolutionary perspective
E Moors, A Rip, JSC Wiskerke
Seeds of transition: essays on novelty production, niches and regimes in …, 2004
782004
Exploring dynamics and strategies of niche protection
WPC Boon, EHM Moors, AJ Meijer
Research Policy 43 (4), 792-803, 2014
762014
Endogenous regime change: lessons from transition pathways in Dutch dairy farming
H Runhaar, L Fünfschilling, A van den Pol-Van Dasselaar, EHM Moors, ...
Environmental Innovation and Societal Transitions 36, 137-150, 2020
752020
The creation of legitimacy in grassroots organisations: A study of Dutch community-supported agriculture
LM Van Oers, WPC Boon, EHM Moors
Environmental Innovation and Societal Transitions 29, 55-67, 2018
742018
Towards a sustainable system of drug development
EHM Moors, AF Cohen, H Schellekens
Drug discovery today 19 (11), 1711-1720, 2014
722014
The complexities in system building strategies—The case of personalized cancer medicines in England
P Kukk, EHM Moors, MP Hekkert
Technological Forecasting and Social Change 98, 47-59, 2015
652015
系统目前无法执行此操作,请稍后再试。
文章 1–20